SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001554795-24-000051
Filing Date
2024-03-12
Accepted
2024-03-12 14:26:31
Documents
15
Period of Report
2024-01-03
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A skin0312form8ka1.htm   iXBRL 8-K/A 28866
  Complete submission text file 0001554795-24-000051.txt   245859

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE skin-20240103.xsd EX-101.SCH 3704
3 XBRL DEFINITION FILE skin-20240103_def.xml EX-101.DEF 26542
4 XBRL LABEL FILE skin-20240103_lab.xml EX-101.LAB 36564
5 XBRL PRESENTATION FILE skin-20240103_pre.xml EX-101.PRE 25166
17 EXTRACTED XBRL INSTANCE DOCUMENT skin0312form8ka1_htm.xml XML 5439
Mailing Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106 8013232395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

IRS No.: 870458170 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-30991 | Film No.: 24741550
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)